top of page
Picture4.jpg

DBS for Essential Tremor: Research Clinical Trial

Modern hospital hallway
Albert John Fenoy, MD

Deep Brain Stimulation (DBS) Therapy for Essential Tremor (ET)

The symptoms of Essential Tremor (ET), the most common movement disorder in adults, are seriously disabling and are only marginally improved by medication alone. Tremor control has improved greatly with the use of deep brain stimulation (DBS) to the ventrointermediate nucleus (Vim) of the thalamus, a node along a circuit of abnormal rhythmic output in ET that travels from the cerebellar dentate nucleus to the contralateral red nucleus and cortex via the dentato-rubro-thalamic tract (DRTt). Recent advances in diffusion imaging have led to the development of tractography techniques where the structural connectivity of fiber tracts such as the DRTt can be illustrated and then, as we have shown, directly targeted during DBS surgery for excellent clinical effect.


Despite such novel targeting methodology and initial tremor improvement, however, the development of side effects such as progressive gait ataxia and waning efficacy after years of chronic stimulation points to the fact that the pathology of essential tremor is poorly understood. Such incomplete knowledge of the network effects of chronic stimulation in ET is a major barrier that needs to be overcome through understanding the dysfunction and modulation of the connectivity of the cerebellar-thalamic-cortical (CTC) network over time.  

Group 564.png

Dr. Fenoy and his team were awarded a $2.1M R01 grant from the National Institute of Neurological Disorders and Stroke to investigate tremor network modulation through imaging in patients already receiving DBS as part of their optimal treatment plan.

​

In this study, MRIs will be used to assess the functional connectivity between different brain regions two years after DBS implantation. At this time point it is believed that the cortical-subcortical network responsible for tremor may have changed relative to baseline. Patients will then be imaged with DBS ON and then will elect to have DBS turned OFF for up to 72hours with repeated imaging, correlated with clinical changes. After 72 hours, DBS will be resumed.

Participation in this study requires 3 successive days of MRIs after at least 2 years of DRTt DBS ON. Patients can elect to complete 1 or all 3 days, for a total of 4 MRIs.


Compensation for completing each MRI is provided, as well as travel to each MRI. Parking fees will be validated. There is no cost for undergoing these MRIs.

Albert John Fenoy, MD
bottom of page